|Bid||21.00 x 800|
|Ask||22.98 x 800|
|Day's range||21.52 - 23.56|
|52-week range||9.12 - 43.32|
|Beta (5Y monthly)||1.16|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||44.00|
Alector, Inc. ( NASDAQ:ALEC ) shareholders might understandably be very concerned that the share price has dropped 33...
Having dropped from the lofty heights it reached only a few short months ago, Alector (NASDAQ: ALEC) stock was having another bad day on Wednesday. After market hours on Tuesday, Alector announced the departure of two high-level executives. It said that chief operating officer Shehnaaz Suliman and chief medical officer Robert Paul will step down following a "transition period," and should continue to serve as advisors to the company until the end of this year.
Shareholders in Alector, Inc. ( NASDAQ:ALEC ) may be thrilled to learn that the analysts have just delivered a major...